Surface treatment method for aluminum alloy and surface treatment method for magnesium alloy
    11.
    发明授权
    Surface treatment method for aluminum alloy and surface treatment method for magnesium alloy 有权
    铝合金表面处理方法及镁合金表面处理方法

    公开(公告)号:US08617321B2

    公开(公告)日:2013-12-31

    申请号:US12443904

    申请日:2007-10-02

    IPC分类号: C23C22/57 C23C22/56 C23C22/05

    CPC分类号: C23C8/02 C23C8/34 C23C28/021

    摘要: The present invention provides a surface treatment method for an aluminum alloy and a surface treatment method for a magnesium alloy, which enable providing the surface of an aluminum alloy containing magnesium or the surface of a magnesium alloy with sufficient corrosion resistance to corrosive gases, while preventing the surface from scattering magnesium therefrom even when used in a vacuum at a temperature of not less than 300° C. In this method, a carbon fluoride compound is applied over the surface of the aluminum alloy containing magnesium or the surface of the magnesium alloy, followed by heating in an oxygen atmosphere, thereby forming a fluoride passivation film.

    摘要翻译: 本发明提供一种铝合金的表面处理方法和镁合金的表面处理方法,其能够提供含有镁或镁合金表面的铝合金的表面,对腐蚀性气体具有足够的耐腐蚀性,同时防止 该表面即使在不低于300℃的温度下在真空中使用时也散射镁。在该方法中,在含有镁或镁合金表面的铝合金的表面上涂布氟化碳化合物, 然后在氧气氛中加热,从而形成氟化钝化膜。

    LIQUID COSMETIC
    12.
    发明申请
    LIQUID COSMETIC 有权
    液体化妆品

    公开(公告)号:US20130330288A1

    公开(公告)日:2013-12-12

    申请号:US14000558

    申请日:2012-04-26

    申请人: Hiroshi Sato

    发明人: Hiroshi Sato

    摘要: To provide a liquid cosmetic which is loaded into a liquid applicator having an applying part and suitably used as a cosmetic for eye-makeup around the eyes, the liquid cosmetic comprises, at least, 1 to 20% by mass of high-brightness particles, 2 to 10% by mass of film-forming resin, 0.3% by mass or more of an anionic polymer compound having a thickening effect, and water, and is configured such that the viscosity at 25° C. and a shear rate of 76.8 s−1 in an EMD type viscometer falls within the range of 250 to 1,000 mPa·s.

    摘要翻译: 为了提供一种液体化妆品,其装载到具有施加部分并适合用作眼睛周围化妆品的液体施加器中,液体化妆品至少包含1至20质量%的高亮度颗粒, 2〜10质量%的成膜树脂,0.3质量%以上的具有增稠效果的阴离子聚合物化合物和水,并且被构造成使得在25℃下的粘度和76.8秒的剪切速率 -1在EMD型粘度计中的范围为250〜1000mPa·s。

    RNA polymerase mutant with improved functions
    13.
    发明授权
    RNA polymerase mutant with improved functions 有权
    具有改善功能的RNA聚合酶突变体

    公开(公告)号:US08551752B2

    公开(公告)日:2013-10-08

    申请号:US13057418

    申请日:2009-08-07

    IPC分类号: C12N9/12

    CPC分类号: C12N9/1247

    摘要: Disclosed is a T7 RNA polymerase mutant having improved thermal stability and/or specific activity in comparison with wild-type T7-like bacteriophage RNA polymerase, wherein at least one amino acid residue corresponding to at least one of the amino acid residues selected from the group at least consisting of glutamine at position 768, lysine at position 179 and valine at position 685 of the amino acid sequence that composes wild-type T7 RNA polymerase shown in SEQ ID NO: 6, is substituted with another amino acid.

    摘要翻译: 公开了与野生型T7样噬菌体RNA聚合酶相比具有改进的热稳定性和/或比活性的T7RNA聚合酶突变体,其中至少一个氨基酸残基对应于选自下组的氨基酸残基 由构成SEQ ID NO:6所示的野生型T7RNA聚合酶的氨基酸序列的768位的谷氨酰胺,179位的赖氨酸和685位的缬氨酸被另一个氨基酸取代。

    Recombinant protein S composition
    14.
    发明授权
    Recombinant protein S composition 失效
    重组蛋白S组成

    公开(公告)号:US08501914B2

    公开(公告)日:2013-08-06

    申请号:US12540501

    申请日:2009-08-13

    IPC分类号: A61K38/16 C12P21/02

    摘要: A pharmaceutical agent for treating a disease such as inflammatory diseases, blood coagulation diseases associated with deficiency of Protein S has been required. The present invention provides a Protein S composition comprising recombinant Protein S molecules having complex type N-glycoside-linked sugar chains, wherein the Protein S has a higher binding activity to a receptor for advanced glycation end products (hereinafter referred to as “RAGE”) than native Protein S present in healthy human blood, and also has a higher ratio of sugar chains in which fucose is not bound to the complex type N-glycoside-linked sugar chains bound to Protein S than native Protein S present in healthy human blood.

    摘要翻译: 需要用于治疗诸如炎性疾病,与蛋白S缺乏相关的血液凝固疾病等疾病的药剂。 本发明提供了包含具有复合型N-糖苷连接的糖链的重组蛋白S分子的蛋白S组合物,其中蛋白S与晚期糖基化终产物的受体(以下称为“RAGE”)具有较高的结合活性, 比存在于健康人血液中的天然蛋白S高,并且与健康人血液中存在的天然蛋白S相比,岩藻糖与其与蛋白S结合的复合型N-糖苷连接的糖链不结合的糖链的比例更高。